Hepion Pharmaceuticals executive chairman LoPriore buys $500,000 in stock
What it means
- What to watch: This one turns on a concrete figure ($500,000); set it against the recent trend before reading it as a turning point.
- How the stock is trading: $HEPA +3.70% in the latest session.
- Timing: It landed while New York slept, so the session change beside it belongs to a day that had already closed. Market holidays are not detected.
Where the stock stands
$HEPA last traded at $0.14, +3.70% on the session. That puts it 9.9% shy of its 52-week high of $0.16 and 312% clear of its low of $0.03 — in the upper part of the range. Over the year it has ranged 357% from low to high: a very wide band — this one has spent the year on a roller coaster, and big swings are business as usual. These are latest-session quotes, not live prices — the live tape is on the $HEPA page.
The bigger picture
Healthcare stories turn on approvals, trial data and pricing: one FDA decision or trial readout can swing a single drugmaker hard, while drug-pricing policy moves the whole group at once. Wook's supply-chain scanner has Health Care reading calm today: no unusual stress in the filings and disclosures it watches.
What to watch next
For the receipts, the $HEPA page has the full chart, the filings and the valuation model these figures come from. Want the facts without the spin? Read how two or three outlets frame the same story — where they agree is the news, where they differ is the angle. And Wook AI, up top, will happily do the math — how far $HEPA sits from its high, or how this week's coverage stacks up.
How this analysis was made
Investing.com published it, and Wook filed it under Healthcare & Pharma. No strongly worded term either way, so it reads neutral at low severity — a factual headline rather than a charged one. It was matched to $HEPA. It carried $500,000, shown as published and not recalculated. The publisher gave no preview text, and nothing has been written in to fill the gap.
The tone and severity labels come from a fixed word list — no editor, no AI, no crystal ball — so they describe how a story is worded, not what happens next. They are not a forecast or a recommendation, and a same-day move does not mean this story caused it. Not investment advice.
Discussion
No one has weighed in yet. Start the discussion on this story.
What happened after this published
Investing.com published this on August 13, 2026. $HEPA has moved +100.00% ($0.07 to $0.14). Measured from the first print available after publication, against the latest available quote. This comparison does not isolate the story's effect.